Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo
Therapy of diseases of the central nervous system is a major challenge since drugs have to overcome the blood-brain barrier (BBB). A powerful strategy to enhance cerebral drug concentration is administration of drug-loaded poly(n-butylcyano-acrylate) (PBCA) nanoparticles coated with polysorbate 80 (...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2015
|
| In: |
Journal of controlled release
Year: 2014, Volume: 197, Pages: 165-179 |
| ISSN: | 1873-4995 |
| DOI: | 10.1016/j.jconrel.2014.11.005 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jconrel.2014.11.005 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0168365914007421 
|
| Author Notes: | Marise Kolter, Melanie Ott, Christian Hauer, Isolde Reimold, Gert Fricker |
| Summary: | Therapy of diseases of the central nervous system is a major challenge since drugs have to overcome the blood-brain barrier (BBB). A powerful strategy to enhance cerebral drug concentration is administration of drug-loaded poly(n-butylcyano-acrylate) (PBCA) nanoparticles coated with polysorbate 80 (PS80). This study evaluates the toxicity of PBCA-nanoparticles at the BBB, representing the target organ, the inflammatory response in human whole blood, as the site of administration and in a rat model in vivo. |
|---|---|
| Item Description: | Available online 10 November 2014 Gesehen am 15.07.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1873-4995 |
| DOI: | 10.1016/j.jconrel.2014.11.005 |